欣母沛与麦角新碱治疗剖宫产子宫收缩乏力性产后出血的临床价值

Clinical value of hemabate and ergometrine in the treatment of postpartum hemorrhage due to uterine atony after cesarean section

目的:探究不同药物联合使用治疗剖宫产子宫收缩乏力性产后出血的效果。方法:2018年2月-2020年4月收治剖宫产术后子宫收缩乏力性产后出血产妇90例,随机分为两组,各45例。常规组采用缩宫素+麦角新碱治疗;研究组采用缩宫素+欣母沛治疗。比较两组治疗效果。结果:研究组治疗总有效率明显高于常规组,差异有统计学意义(P<0.05);研究组产后2 h及24 h出血量均明显低于常规组,差异有统计学意义(P<0.05);研究组术后血红蛋白水平明显高于常规组,差异有统计学意义(P<0.05)。结论:采用缩宫素+欣母沛治疗剖宫产术后子宫收缩乏力性产后出血产妇,可提高治疗效果,减少产后出血。

Objective:To explore the effect of different drugs combined in the treatment of postpartum hemorrhage due to uterine atony after cesarean section.Methods:From February 2018 to April 2020,90 cases of postpartum hemorrhage due to uterine atony after cesarean section were selected and randomly divided into two groups with 45 cases in each group.The conventional group was treated with oxytocin and ergometrine.The study group was treated with oxytocin and hemabate.We compared the treatment effect of the two groups.Results:In the study group,the total effective rate was significantly higher than that in the conventional group,the difference was statistically significant(P<0.05).In the study group,the amount of postpartum bleeding at 2 hours and 24 hours was significantly lower than that in the conventional group,the difference was statistically significant(P<0.05).In the study group,the postoperative hemoglobin level was significantly higher than that in the conventional group,the difference was statistically significant(P<0.05).Conclusion:Using oxytocin and hemabate to treat postpartum hemorrhage due to uterine atony after cesarean section can improve the therapeutic effect and reduce postpartum hemorrhage.